Cargando…

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies

INTRODUCTION: Resveratrol, an activator for longevity regulatory genes-sirtuin family (SIRTs) and Sirtuin 2 (SIRT2) is an important factor of SIRTs which demonstrated biological function in cancers, but the underlying mechanism is unrevealed. METHODS: We investigated the mRNA and protein levels of S...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jian, Qiu, Nianxiang, Zhou, Xianchao, Meng, Mei, Liu, Zixue, Li, Jingquan, Du, Shiyu, Sun, Zhiqiang, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947150/ https://www.ncbi.nlm.nih.gov/pubmed/36844923 http://dx.doi.org/10.3389/fonc.2022.1007653

Ejemplares similares

In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells
por: Duan, JingJing, et al.
Publicado: (2016)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients
por: Meng, Mei, et al.
Publicado: (2023)

Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Kaplon, Hélène
Publicado: (2022)

Immunomodulation of NK Cells by Ionizing Radiation
por: Chen, Jiarui, et al.
Publicado: (2020)

Ab Initio Studies of Structural and Mechanical Properties of NH(3), NO, and N(2)O Hydrates
por: Sun, Ningru, et al.
Publicado: (2023)

First-principles study on the structure and electronic properties of M(2)CS(x) (M = Sc, Ti, Y, Zr and Hf, x = 1, 2)
por: Zhu, Huaijin, et al.
Publicado: (2023)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Harnessing immunomodulation during DNA damage in Ewing sarcoma
por: Daley, Jessica D., et al.
Publicado: (2022)

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy
por: Mokhtari, Reza Bayat, et al.
Publicado: (2021)

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
por: Yuan, Meng, et al.
Publicado: (2022)

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
por: Peng, Jianfeng, et al.
Publicado: (2021)

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
por: Xiang, Luochengling, et al.
Publicado: (2020)

Combinations of Immunotherapy and Radiation in Cancer Therapy
por: Vatner, Ralph E., et al.
Publicado: (2014)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Protective effects and immunomodulation on piglets infected with rotavirus following resveratrol supplementation
por: Cui, Qiankun, et al.
Publicado: (2018)

Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

Editorial: Cancer Cell Metabolism and Immunomodulation in the Context of Tumor Metastasis
por: Dong, Qiongzhu, et al.
Publicado: (2022)

Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients
por: Wang, Zhe, et al.
Publicado: (2021)

Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma
por: Hu, Chun-Hong, et al.
Publicado: (2022)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment
por: Vagia, Elena, et al.
Publicado: (2015)

Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
por: Jiang, Cheng-Tao, et al.
Publicado: (2021)

Leishmanicidal Effect of Synthetic trans-Resveratrol Analogs
por: Passos, Carlos Luan Alves, et al.
Publicado: (2015)

Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol
por: Pan, Zhiqiang, et al.
Publicado: (2008)

Clinical opportunities in combining immunotherapy with radiation therapy
por: Finkelstein, Steven E., et al.
Publicado: (2012)

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
por: Yu, Siting, et al.
Publicado: (2022)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

JAG1 is correlated to suppressive immune microenvironment and predicts immunotherapy resistance in lung adenocarcinoma
por: He, Jing, et al.
Publicado: (2023)

Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
por: Wang, Qian, et al.
Publicado: (2022)

Antibody therapy: Substitution-immunomodulation -monoclonal immunotherapy
por: Mehra, Narinder K.
Publicado: (2019)

Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment
por: Papademetrio, Daniela L., et al.
Publicado: (2021)

Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
por: Liu, Wenzhi, et al.
Publicado: (2019)

Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy
por: Kawakami, Yutaka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9nseln725okajgqdc0j8aceq13